Literature DB >> 7565352

Dosimetry of interstitial brachytherapy sources: recommendations of the AAPM Radiation Therapy Committee Task Group No. 43. American Association of Physicists in Medicine.

R Nath1, L L Anderson, G Luxton, K A Weaver, J F Williamson, A S Meigooni.   

Abstract

Mesh：

Substances：

Year:  1995        PMID： 7565352     DOI： 10.1118/1.597458

Source DB:  PubMed          Journal:  Med Phys        ISSN： 0094-2405            Impact factor:   4.071


× No keyword cloud information.
  247 in total

1.  Comparison of seed brachytherapy or external beam radiotherapy (70 Gy or 74 Gy) in 919 low-risk prostate cancer patients.

Authors:  G Goldner; R Pötter; J J Battermann; M P Schmid; C Kirisits; S Sljivic; M van Vulpen
Journal:  Strahlenther Onkol       Date:  2012-02-22       Impact factor: 3.621

2.  Impact of source-production revision on the dose-rate constant of 131Cs interstitial brachytherapy sources.

Authors:  Zhe Chen; Paul Bongiorni; Ravinder Nath
Journal:  Med Phys       Date:  2010-07       Impact factor: 4.071

3.  GATE: a simulation toolkit for PET and SPECT.

Authors:  S Jan; G Santin; D Strul; S Staelens; K Assié; D Autret; S Avner; R Barbier; M Bardiès; P M Bloomfield; D Brasse; V Breton; P Bruyndonckx; I Buvat; A F Chatziioannou; Y Choi; Y H Chung; C Comtat; D Donnarieix; L Ferrer; S J Glick; C J Groiselle; D Guez; P F Honore; S Kerhoas-Cavata; A S Kirov; V Kohli; M Koole; M Krieguer; D J van der Laan; F Lamare; G Largeron; C Lartizien; D Lazaro; M C Maas; L Maigne; F Mayet; F Melot; C Merheb; E Pennacchio; J Perez; U Pietrzyk; F R Rannou; M Rey; D R Schaart; C R Schmidtlein; L Simon; T Y Song; J M Vieira; D Visvikis; R Van de Walle; E Wieërs; C Morel
Journal:  Phys Med Biol       Date:  2004-10-07       Impact factor: 3.609

4.  Preliminary study of correction of original metal artifacts due to 1-125 seeds in postimplant dosimetry for prostate permanent implant brachytherapy.

Authors:  Yutaka Takahashi; Shinichiro Mori; Takuyo Kozuka; Kotaro Gomi; Takayuki Nose; Takatoshi Tahara; Masahiko Oguchi; Takashi Yamashita
Journal:  Radiat Med       Date:  2006-02

5.  Visual acuity, oncologic, and toxicity outcomes with 103Pd vs. 125I plaque treatment for choroidal melanoma.

Authors:  Kirtesh R Patel; Roshan S Prabhu; Jeffrey M Switchenko; Mudit Chowdhary; Caroline Craven; Pia Mendoza; Hasan Danish; Hans E Grossniklaus; Thomas M Aaberg; Thomas Aaberg; Sahitya Reddy; Elizabeth Butker; Chris Bergstrom; Ian R Crocker
Journal:  Brachytherapy       Date:  2017-03-03       Impact factor: 2.362

6.  A systematic evaluation of the dose-rate constant determined by photon spectrometry for 21 different models of low-energy photon-emitting brachytherapy sources.

Authors:  Zhe Jay Chen; Ravinder Nath
Journal:  Phys Med Biol       Date:  2010-09-24       Impact factor: 3.609

7.  Preimplant factors affecting postimplant CT-determined prostate volume and the CT/TRUS volume ratio after transperineal interstitial prostate brachytherapy with 125I free seeds.

Authors:  Akitomo Sugawara; Jun Nakashima; Etsuo Kunieda; Hirohiko Nagata; Hirotaka Asakura; Mototsugu Oya; Naoyuki Shigematsu
Journal:  Radiat Oncol       Date:  2010-09-28       Impact factor: 3.481

8.  On the need to compensate for edema-induced dose reductions in preplanned (131)Cs prostate brachytherapy.

Authors:  Z Jay Chen; Jun Deng; Kenneth Roberts; Ravinder Nath
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-11-05       Impact factor: 7.038

Review 9.  Magnetic resonance image guided brachytherapy.

Authors:  Kari Tanderup; Akila N Viswanathan; Christian Kirisits; Steven J Frank
Journal:  Semin Radiat Oncol       Date:  2014-07       Impact factor: 5.934

10.  A comparison of acute and chronic toxicity for men with low-risk prostate cancer treated with intensity-modulated radiation therapy or (125)I permanent implant.

Authors:  Thomas N Eade; Eric M Horwitz; Karen Ruth; Mark K Buyyounouski; David J D'Ambrosio; Steven J Feigenberg; David Y T Chen; Alan Pollack
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-01-22       Impact factor: 7.038
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.